Evidence map›Paper›PMID 26683317›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2016

Genome-Based Infection Tracking Reveals Dynamics of Clostridium difficile Transmission and Disease Recurrence.

Nitin Kumar, Fabio Miyajima, Miao He, Paul Roberts, Andrew Swale, Louise Ellison, Derek Pickard, Godfrey Smith, Rebecca Molyneux, Gordon Dougan and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Observational
  3. Integrated Genomic and Social Network Analyses of SARS-CoV-2 Transmission in the Healthcare Setting.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  4. Article
  5. Article
  6. Comparative Genomics of Clostridioides difficile.Advances in experimental medicine and biology · 2024
    Article
  7. Review
  8. Article
  9. Evidence of within-facility patient-patientEpidemiology and infection · 2022
    Article
  10. Review
  11. Genomic Determination of Relative Risks for Clostridioides difficile Infection From Asymptomatic Carriage in Intensive Care Unit Patients.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  12. Clostridioides difficile Whole-genome Sequencing Differentiates Relapse With the Same Strain From Reinfection With a New Strain.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  13. Clinics in colon and rectal surgery · 2020
    Review
  14. High Prevalence of Genetically RelatedFrontiers in microbiology · 2020
    Article
  15. Article
  16. Article
  17. Genomics of the Pathogenic Clostridia.Microbiology spectrum · 2019
    Review
  18. EpidemicOpen forum infectious diseases · 2019
    Article
  19. Clostridium difficile: Investigating Transmission Patterns Between Infected and Colonized Patients Using Whole Genome Sequencing.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Nitin KumarWellcomeTrust Sanger Institute, Hinxton.
Fabio MiyajimaUniversity of Liverpool.
Miao HeWellcomeTrust Sanger Institute, Hinxton.
Paul RobertsRoyal Liverpool and Broadgreen University Hospitals NHS Trust.
Andrew SwaleUniversity of Liverpool.
Louise EllisonWellcomeTrust Sanger Institute, Hinxton.
Derek PickardWellcomeTrust Sanger Institute, Hinxton.
Godfrey SmithRoyal Liverpool and Broadgreen University Hospitals NHS Trust.
Rebecca MolyneuxRoyal Liverpool and Broadgreen University Hospitals NHS Trust.
Gordon DouganWellcomeTrust Sanger Institute, Hinxton.
Julian ParkhillWellcomeTrust Sanger Institute, Hinxton.
Brendan W WrenLondon School of Hygiene and Tropical Medicine, United Kingdom.
Christopher M ParryLondon School of Hygiene and Tropical Medicine, United Kingdom.
Munir PirmohamedUniversity of Liverpool.
Trevor D LawleyWellcomeTrust Sanger Institute, Hinxton.
Royal Liverpool and Broadgreen University Hospital NHS Trust · GBUniversity of Liverpool · GBLondon School of Hygiene & Tropical Medicine · GB

Funding

Medical Research Council G0700654Medical Research Council MR/K000551/1Medical Research Council MR/L006758/1Medical Research Council PF451Wellcome Trust 098051
6 · The paper itself

Abstract

backgroundAccurate tracking of Clostridium difficile transmission within healthcare settings is key to its containment but is hindered by the lack of discriminatory power of standard genotyping methods. We describe a whole-genome phylogenetic-based method to track the transmission of individual clones in infected hospital patients from the epidemic C. difficile 027/ST1 lineage, and to distinguish between the 2 causes of recurrent disease, relapse (same strain), or reinfection (different strain).

methodsWe monitored patients with C. difficile infection in a UK hospital over a 2-year period. We performed whole-genome sequencing and phylogenetic analysis of 108 strains isolated from symptomatic patients. High-resolution phylogeny was integrated with in-hospital transfers and contact data to create an infection network linking individual patients and specific hospital wards.

resultsEpidemic C. difficile 027/ST1 caused the majority of infections during our sampling period. Integration of whole-genome single nucleotide polymorphism (SNP) phylogenetic analysis, which accurately discriminated between 27 distinct SNP genotypes, with patient movement and contact data identified 32 plausible transmission events, including ward-based contamination (66%) or direct donor-recipient contact (34%). Highly contagious donors were identified who contributed to the persistence of clones within distinct hospital wards and the spread of clones between wards, especially in areas of intense turnover. Recurrent cases were identified between 4 and 26 weeks, highlighting the limitation of the standard <8-week cutoff used for patient diagnosis and management.

conclusionsGenome-based infection tracking to monitor the persistence and spread of C. difficile within healthcare facilities could inform infection control and patient management.

Indexed as

Genome, BacterialAdultClostridioides difficileClostridium InfectionsCross InfectionDisease OutbreaksFemaleGenotypeHospitalizationHumansMaleMiddle AgedPhylogenyPolymorphism, Single NucleotideRecurrenceRibotypingC. difficile 027/ST1highly contagious individualsrecurrenceward-based transmissionwhole-genome sequencing

Identifiers

PMID26683317
PMCPMC4772841
OpenAlexW2216327541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.